Wikidata entity: Q64649369
Quantities
| P2899 | minimum age | 50 |
| P1132 | number of participants | 10 |
| P6099 | clinical trial phase | ... | Q42824440 (phase II clinical trial) | phase II clinical trial |
| P17 | country | ... | Q30 (United States) | United States |
| P582 | end time | ... | 2015-12-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P1050 | medical condition | ... | Q1752891 (polymyalgia rheumatica) | polymyalgia rheumatica |
| P580 | start time | ... | 2011-04-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | Phase IIa of Tocilizumab In the Treatment of Polymyalgia Rheumatica | ??? |
| P3098 | ClinicalTrials.gov ID | NCT01396317 |
Why not click here or view trends?
log id: 4794591